Table 3. Meta-analysis results by ethnicity.

Outcome	Ethnicity	N^	Patients, n	Mut&, (%)	Fixed	Random	Heterogeneity		Subgroup Differences
AML					RRs* 95%CI	RRs 95%CI	P	I2	Fixed		Random
									P	I2	P	I2
CR
t(8,21)
	Caucasian	4	411	82(20)	0.61 [0.19, 1.95]	0.70 [0.21, 2.30]	0.73	0%
	non-Caucasian	5	315	115(37)	2.03 [1.02, 4.05]	2.06 [1.01, 4.22]	0.41	0%	0.08	67%	0.13	57%
inv(16)
	Caucasian	5	527	166(31)	0.80 [0.41, 1.59]	0.87 [0.43, 1.77]	0.51	0%
	non-Caucasian	4	127	40(31)	1.96 [0.50, 7.72]	2.13 [0.47, 9.68]	0.31	3%	0.25	23%	0.30	9%
OS
t(8,21)
	Caucasian	3	362	71(20)	1.12 [0.90, 1.40]	1.06 [0.80, 1.40]	0.26	27%
	non-Caucasian	3	136	42(31)	2.26 [1.35, 3.78]	2.22 [1.33, 3.70]	0.82	0%	0.01	84%	0.01	84%
inv(16)
	Caucasian	5	527	166(31)	1.02 [0.88, 1.18]	1.01 [0.83, 1.25]	0.12	45%
	non-Caucasian	3	110	32(29)	1.08 [0.79,1.47]	1.01 [0.74, 1.36]	0.34	7%	0.75	0%	0.97	0%
Relapse Risk
t(8,21)
5y	Caucasian	3	341	75(22)	1.55 [1.10, 2.18]	1.60 [1.14, 2.23]	0.70	0%
2y	non-Caucasian	5	278	96(35)	1.89 [1.51, 2.37]	1.91 [1.41, 2.57]	0.26	24%
4y	non-Caucasian	3	123	34(28)	2.33 [1.59, 3.41]	2.87 [1.15, 7.15]	0.16	45%
5y	non-Caucasian	2	77	26(34)	2.03 [1.37, 3.01]	2.00 [1.35, 2.96]	0.58	0%	0.34	0%	0.44	0%
inv(16)
5y	Caucasian	3	286	83(29)	1.18 [0.92, 1.52]	1.22 [0.78, 1.90]	0.11	55%
	non-Caucasian	3	101	28(28)	0.94 [0.56, 1.58]	0.57 [0.10, 3.45]	0.07	52%	0.44	0%	0.43	0%

^{^} N: Studies included.

^* ORs for CR, and RRs for OS and relapse rate.

^& Numbers of patients with KIT-mutations.